EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A Randomized Double-blind, Placebo-controlled Trial of Adipose-derived Regenerative Cells Injected into Corpora Cavernosum Following Radical Prostatectomy

Sabrina Toft Hansen, Ditte Caroline Andersen, Charlotte Harken Jensen, Per Damkier, Jens Ahm Sørensen, Lars Lund

European Urology Focus · 2026

DOI: 10.1016/j.euf.2026.02.002 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Urology Focus, 2026. Verfasst von Sabrina Toft Hansen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark;…. Hauptthemen laut MEDLINE: Prostatectomy, Erectile Dysfunction, Adipose Tissue, Penis. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danmarks Frie Forskningsfond Sundhed og Sygdom.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVE: Erectile dysfunction (ED) following radical prostatectomy (RP) has a negative impact on quality of life. Herein, the aim was to assess the effectiveness of autologous adipose-derived regenerative cells (ADRCs) for treating ED after RP. METHODS: This was a randomized, double-blinded, placebo-controlled study. A total of 70 men with ED were enrolled at Odense University Hospital, Denmark. Patients received one intracavernous bolus of ADRCs (n = 35) or placebo (n = 35). The primary endpoint was a change in the International Index of Erectile Function 5 (IIEF-5) at 12 mo after intervention versus baseline. The secondary endpoints were changes in Erectile Hardness Scale (EHS) and RigiScan values at 6 mo versus baseline. KEY FINDINGS AND LIMITATIONS: There was no significant difference between the two groups in IIEF-5 (p > 0.99) and EHS (p = 0.85) scores. RigiScan values showed no overall effect of ADRCs versus placebo (tumescence activity units at the tip of the penis p = 0.19 and the base of the penis p = 0.60, and rigidity activity units at the tip of the penis p = 0.97 and the base of the penis p = 1). No severe adverse events were observed, and none had prostate-specific antigen relapse. Study limitations include the use of online surveys for patient registration of IIEF-5 and EHS scores. CONCLUSIONS AND CLINICAL IMPLICATIONS: Intracavernous injections of ADRCs appear safe, but had no measurable effect on ED after RP and thus cannot be recommended in its current form.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstatectomyErectile DysfunctionAdipose TissuePenisPostoperative ComplicationsHumansMaleDouble-Blind MethodMiddle AgedAgedTreatment OutcomeQuality of LifeProstatic NeoplasmsTransplantation, Autologous

Stichwörter der Autor:innen

Adipose-derived stem cellsCell therapyClinical trialErectile dysfunctionProstate cancerRadical prostatectomy

Autor:innen und Institutionen

  • Department of Urology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Center for Vascular Regeneration, Odense University Hospital, Odense,…
  • Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Center for Vascular Regeneration, Odense University Hospital, Odense, Denmark; Andersen Group, University of Southern Denmark, Odense, De…
  • Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Center for Vascular Regeneration, Odense University Hospital, Odense, Denmark; Research Unit for Plastic Surgery, Odense University Hospi…

Förderung

  • Danmarks Frie Forskningsfond Sundhed og Sygdom

Zitieren

APA

Hansen, S. T., Andersen, D. C., Jensen, C. H., Damkier, P., Sørensen, J. A., & Lund, L. (2026). A Randomized Double-blind, Placebo-controlled Trial of Adipose-derived Regenerative Cells Injected into Corpora Cavernosum Following Radical Prostatectomy. European Urology Focus. https://doi.org/10.1016/j.euf.2026.02.002

Vancouver

Hansen ST, Andersen DC, Jensen CH, Damkier P, Sørensen JA, Lund L. A Randomized Double-blind, Placebo-controlled Trial of Adipose-derived Regenerative Cells Injected into Corpora Cavernosum Following Radical Prostatectomy. European Urology Focus. 2026. doi:10.1016/j.euf.2026.02.002

BibTeX
@article{Hansen2026,
  author = {Hansen, Sabrina Toft and Andersen, Ditte Caroline and Jensen, Charlotte Harken and Damkier, Per and Sørensen, Jens Ahm and Lund, Lars},
  title = {A Randomized Double-blind, Placebo-controlled Trial of Adipose-derived Regenerative Cells Injected into Corpora Cavernosum Following Radical Prostatectomy},
  journal = {European Urology Focus},
  year = {2026},
  doi = {10.1016/j.euf.2026.02.002}
}
Kostenlos starten →